Recent clinical trials have shown that baricitinib is safe and effective for treating patients with rheumatoid arthritis who have proved non-responsive to multiple biologic treatments…
Search results for: nonmelanoma skin cancer
German Registry Evaluates Systemic Psoriasis Treatments
The German Psoriasis Registry, PsoBest, found conventional systemic and biologic drugs for psoriasis demonstrated relative safety from serious adverse events in patients between January 2008–December 2012…
Nuclear Medicine Exposures Up Health Risks for Radiology Techs
NEW YORK (Reuters Health)—Technologists working in nuclear medicine have a heightened risk for some cancers and myocardial infarction, according to a nationwide U.S. survey led by National Cancer Institute (NCI) researchers. “Our results were mainly driven by exposures occurring before 1980, which is consistent with evidence that most cancers and other serious radiation-related chronic disease…
Decernotinib, Subcutaneous Methotrexate Drug Updates, Trials, Approvals
Plus, rheumatology drug news, safety updates
Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis
Small molecule kinase inhibitors, such as JAK inhibitors, provide a novel route for rheumatic disease treatment—and may promote our understanding of the immune system’s complexities
Drug Updates
Information on new approvals and medication safety
Are We Playing It Safe?
Tumor necrosis factor alpha inhibition and the risk of solid malignancies